| 摘要 |
<p>The present invention relates to haemodialysis concentrates used to make ready-for-use haemodialysis solutions applicable in patients with both acute and chronic renal failure, diabetes and intoxication. The obtained haemodialysis concentrates contain according to the invention electrolytes, a buffer, an osmotic agent, and an antioxidant selected from the group including glutathione, N-acetyl-L-cysteine, and its pharmaceutically acceptable salts or ±-lipoic acid and is in dry or liquid form. They are used to prepare a haemodialysis solution to reduce undesirable complications of renal failure including cardiovascular diseases, renal anaemia, renal osteodystrophy, microinflammatory processes, malnutrition, polyneuropathy, and/or encephalopathy. The haemodialysis concentrates and the haemodialysis solutions prepared therefrom according to the present invention are stable and undergo no physicochemical changes and interactions.</p> |
